http://purl.org/np/RAGkiNKRuSu0abYLl_ybZIUn_IhTZMLyQA804hqY8AiGM#Head
http://purl.org/np/RAGkiNKRuSu0abYLl_ybZIUn_IhTZMLyQA804hqY8AiGM
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAGkiNKRuSu0abYLl_ybZIUn_IhTZMLyQA804hqY8AiGM#assertion
http://purl.org/np/RAGkiNKRuSu0abYLl_ybZIUn_IhTZMLyQA804hqY8AiGM
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAGkiNKRuSu0abYLl_ybZIUn_IhTZMLyQA804hqY8AiGM#provenance
http://purl.org/np/RAGkiNKRuSu0abYLl_ybZIUn_IhTZMLyQA804hqY8AiGM
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAGkiNKRuSu0abYLl_ybZIUn_IhTZMLyQA804hqY8AiGM#pubinfo
http://purl.org/np/RAGkiNKRuSu0abYLl_ybZIUn_IhTZMLyQA804hqY8AiGM
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAGkiNKRuSu0abYLl_ybZIUn_IhTZMLyQA804hqY8AiGM#assertion
http://purl.obolibrary.org/obo/DOID_2050
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAGkiNKRuSu0abYLl_ybZIUn_IhTZMLyQA804hqY8AiGM#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_2050
http://purl.org/np/RAGkiNKRuSu0abYLl_ybZIUn_IhTZMLyQA804hqY8AiGM#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAGkiNKRuSu0abYLl_ybZIUn_IhTZMLyQA804hqY8AiGM#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB01416
http://purl.org/np/RAGkiNKRuSu0abYLl_ybZIUn_IhTZMLyQA804hqY8AiGM#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAGkiNKRuSu0abYLl_ybZIUn_IhTZMLyQA804hqY8AiGM#association
http://www.w3.org/2000/01/rdf-schema#label
cefpodoxime proxetil is indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below recommended dosages durations of therapy and applicable patient populations vary among these infections please see dosage and administration acute otitis media streptococcus pneumoniae streptococcus pyogenes haemophilus influenzae moraxella branhamella catarrhalis pharyngitis and or tonsillitis streptococcus pyogenes note community acquired pneumonia s pneumoniae h influenzae acute bacterial exacerbation of chronic bronchitis s pneumoniae h influenzae m catarrhalis h influenzae acute uncomplicated urethral and cervical gonorrhea neisseria gonorrhoeae acute uncomplicated ano rectal infections in women neisseria gonorrhoeae note n gonorrhoeae n gonorrhoeae uncomplicated skin and skin structure infections staphylococcus aureus streptococcus pyogenes note dosage and administration acute maxillary sinusitis haemophilus influenzae streptococcus pneumoniae moraxella catarrhalis uncomplicated urinary tract infections cystitis escherichia coli klebsiella pneumoniae proteus mirabilis staphylococcus saprophyticus note clinical studies appropriate specimens for bacteriological examination should be obtained in order to isolate and identify causative organisms and to determine their susceptibility to cefpodoxime therapy may be instituted while awaiting the results of these studies once these results become available antimicrobial therapy should be adjusted accordingly to reduce the development of drug resistant bacteria and maintain the effectiveness of cefpodoxime proxetil for oral suspension usp and other antibacterial drugs cefpodoxime proxetil for oral suspension usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria when culture and susceptibility information are available they should be considered in selecting or modifying antibacterial therapy in the absence of such data local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy
http://purl.org/np/RAGkiNKRuSu0abYLl_ybZIUn_IhTZMLyQA804hqY8AiGM#association
https://w3id.org/biolink/vocab/association_type
https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation
http://purl.org/np/RAGkiNKRuSu0abYLl_ybZIUn_IhTZMLyQA804hqY8AiGM#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAGkiNKRuSu0abYLl_ybZIUn_IhTZMLyQA804hqY8AiGM#association
https://w3id.org/biolink/vocab/relation
https://schema.org/TreatmentIndication
https://identifiers.org/drugbank:DB01416
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAGkiNKRuSu0abYLl_ybZIUn_IhTZMLyQA804hqY8AiGM#provenance
http://purl.org/np/RAGkiNKRuSu0abYLl_ybZIUn_IhTZMLyQA804hqY8AiGM#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAGkiNKRuSu0abYLl_ybZIUn_IhTZMLyQA804hqY8AiGM#pubinfo
http://purl.org/np/RAGkiNKRuSu0abYLl_ybZIUn_IhTZMLyQA804hqY8AiGM#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAGkiNKRuSu0abYLl_ybZIUn_IhTZMLyQA804hqY8AiGM#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RAGkiNKRuSu0abYLl_ybZIUn_IhTZMLyQA804hqY8AiGM#sig
http://purl.org/nanopub/x/hasSignature
WSy/0DEUewZS7mgqRIKOYQLbiR5kOlZuy+798hg90WHMUvIA9ow2NLi6DGm4hbUV5lESwYsrP1BlXb/ZfLj17JUNRYuEdgERo96GDqkl+/QQaenXy8WuxGaBN8fh1aIvUg7kZS7HctPAEAyw0+KElA/zfkAmlSUEyoq4QK/IMFA=
http://purl.org/np/RAGkiNKRuSu0abYLl_ybZIUn_IhTZMLyQA804hqY8AiGM#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAGkiNKRuSu0abYLl_ybZIUn_IhTZMLyQA804hqY8AiGM
http://purl.org/np/RAGkiNKRuSu0abYLl_ybZIUn_IhTZMLyQA804hqY8AiGM
http://purl.org/dc/terms/created
2021-06-13T15:58:27.043+02:00
http://purl.org/np/RAGkiNKRuSu0abYLl_ybZIUn_IhTZMLyQA804hqY8AiGM
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAGkiNKRuSu0abYLl_ybZIUn_IhTZMLyQA804hqY8AiGM
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAGkiNKRuSu0abYLl_ybZIUn_IhTZMLyQA804hqY8AiGM
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAGkiNKRuSu0abYLl_ybZIUn_IhTZMLyQA804hqY8AiGM
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs